While CROs and healthcare have continued to raise awareness about the lack of diversity within clinical trials, actually addressing the issue remains a huge challenge.
So, what are companies doing to improve the situation? And what practical steps will be taken to ensure more diverse clinical trials in the future?
To find out, I spoke to a panel including three clinical trial experts in a live webinar:
- Matt Walz, CEO of Trialbee
- John Reites, CEO of THREAD
- Stuart Goldblatt, former Chief of Organisational Effectiveness at Covance and a current operational effectiveness & strategy leader.
Together, we spoke about decentralised trials, telehealth, engaging rural populations and more. To receive a downloadable PDF of all the event's major takeaways, click here.
This is only the beginning of addressing diversity in clinical trials and I'm aware of how important diverse voices are. So, CM Life Science will continue to provide podcasts, articles and webinars on this. If you’d like to get involved or know anyone who would – please get in touch. My email is Elisabeth.Edmonds@lifesci-cm.com.
For more about myself and more of my content on the clinical trial space, visit my profile page.
Featuring Synda Clements, Director of Talent Acquisition at ConcertAI.
Pandemic-led supply chain disruption continues to threaten CDMO activity. How can the industry overcome and maybe even thrive? I explore just that.
Talent scarcity is hard to solve in the current climate, but developing a strategy of substance for attracting top-tier candidates is the ultimate way to stand out and win the right people. Here, I delve into how to do just that.
Comments.